TWM
GILD icon

Triton Wealth Management’s Gilead Sciences GILD Stock Holding History

Triton Wealth Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$203K Hold
1,492
– – 0.06% 126
2026
Q1 		$209K Hold
1,492
– – 0.08% 117
2025
Q4 		$216K Buy
+1,492
New +$181K 0.08% 112
2020
Q2 		– Sell
-8,527
Closed -$676K – 84
2020
Q1 		$676K Buy
+8,527
New +$589K 1.09% 20

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Triton Wealth Management's GILD Position: Q2 2026 in Review

Triton Wealth Management held its Gilead Sciences (GILD) position steady in Q2 2026 at 1,492 shares worth $203K. The position accounts for 0.06% of the portfolio, ranked #126.

Triton Wealth Management first reported a position in GILD in Q1 2020 and has held it in 4 quarters since. The position peaked at $676K in Q1 2020. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Triton Wealth Management held 1,492 shares of Gilead Sciences worth $203K as of Q2 2026.
  • Triton Wealth Management left its Gilead Sciences share count unchanged in Q2 2026.
  • Gilead Sciences made up 0.06% of Triton Wealth Management's portfolio in Q2 2026, its #126 holding.
  • Triton Wealth Management first reported a position in Gilead Sciences in Q1 2020 and has held it in 4 quarters since.
  • Triton Wealth Management's Gilead Sciences position peaked at $676K in Q1 2020.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Triton Wealth Management's 13F filing for Q2 2026, filed 5 Aug 2026.